XIANYANG, China, April 5 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (“Biostar” or “the Company”), the Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsule (“Xin Aoxing”), and other pharmaceutical products, today supplements its earlier 2009 earnings release and provides fourth quarter results.
For more information about the non-GAAP financial measures contained in this press release, please see “About Non-GAAP Financial Measures” below.
2010 Guidance, Balance Sheet and Cash Flow Summary
About Non-GAAP Financial Measures
About Biostar Pharmaceuticals, Inc.
Safe Harbor
Biostar Pharmaceuticals, Inc.
